Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Cardiol. Nov 26, 2011; 3(11): 367-373
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.367
Table 2 Baseline clinical characteristics of the study population (n = 138)
n (%)
Age (mean ± SD, yr)70.7 ± 9.3
Female29 (21.0)
Hypertension95 (68.8)
Diabetes mellitus44 (31.8)
Dyslipidemia73 (52.9)
Smoking34 (24.6)
Renal failure30 (21.7)
Previous stroke25 (18.1)
Vasculopathy22 (15.9)
Previous coronary artery bypass graft32 (23.1)
Previous percutaneous coronary intervention21 (15.2)
Previous myocardial infarction46 (33.3)
Charlson score (mean ± SD)4.3 ± 1.6
Clinical presentation
Asymptomatic12 (8.7)
Stable angina45 (32.6)
NSTEMI58 (42.0)
STEMI21 (15.2)
Indication to AVK treatment
Atrial fibrillation93 (67)
CHADS2 00 (0)
CHADS2 169 (75)
CHADS2 ≥ 224 (25)
Pulmonary emboli4 (2.9)
Systemic emboli4 (2.9)
Isolated cardiomyopathy14 (10.1)
Mechanical valve prosthesis22 (15.2)
Thrombus in left ventricle2 (1.4)
Number of diseased vessels
179 (57.2)
241 (29.7)
316 (11.6)
Number of treated vessels
1118 (85.5)
220 (14.5)
Vessels diseased
Left main13
Left anterior descending85
Left circumflex52
Right coronary artery69
Saphenous vein graft4